Shared features of transcription: mutational analysis of the eosinophil/basophil Charcot-Leyden crystal protein gene promoter

被引:14
作者
Dyer, KD
Rosenberg, HF
机构
[1] NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA
[2] Georgetown Univ, Dept Physiol & Biophys, Washington, DC USA
关键词
hematopoiesis;
D O I
10.1002/jlb.67.5.691
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The lineage-specific Charcot-Leyden crystal (CLC) protein is found in human eosinophils and basophils where it comprises 7-10% of the cellular protein content, Previous work from our laboratory has identified the motif GGAGA[A/G] as a powerful enhancer of gene transcription in two eosinophil ribonuclease genes. To evaluate a potentially larger role for this motif in the transcriptional regulation of eosinophil genes, we have isolated 1504 nucleotides 5' to the transcriptional start site of the gene encoding CLC protein and identified a functionally active promoter that includes three distinct copies of the GGAGAA motif. Destruction of only one of the three motifs by site-directed mutagenesis resulted in loss of promoter activity (73 +/- 6% reduction), suggesting that this core motif is necessary but not sufficient to support enhanced transcriptional activity. Sequence comparisons and site-specific mutagenesis has permitted further delineation of this enhancer element which, as a result of this work, is now defined as GGAGA[A/G]NNNA. Electromobility shift assays demonstrated specific binding of nuclear protein(s) from an eosinophilic clone-15 nuclear extract to this extended motif, Similar analysis of a GATA-1 binding site demonstrated enhancer activity, with mutagenesis resulting in a 94 +/- 1.4% reduction in activity, whereas the AML1 site functioned as a gene silencer.
引用
收藏
页码:691 / 698
页数:8
相关论文
共 30 条
[11]   HUMAN EOSINOPHIL MAJOR BASIC-PROTEIN, A MEDIATOR OF ALLERGIC INFLAMMATION, IS EXPRESSED BY ALTERNATIVE SPLICING FROM 2 PROMOTERS [J].
LI, MS ;
SUN, L ;
SATOH, T ;
FISHER, LM ;
SPRY, CJF .
BIOCHEMICAL JOURNAL, 1995, 305 :921-927
[12]   Regulation of eosinophil-specific gene expression by a C/EBP-Ets complex and GATA-1 [J].
McNagny, KM ;
Sieweke, MH ;
Döderlein, G ;
Graf, T ;
Nerlov, C .
EMBO JOURNAL, 1998, 17 (13) :3669-3680
[13]   PEBP2/CBF, THE MURINE HOMOLOG OF THE HUMAN MYELOID AML1 AND PEBP2-BETA/CBF-BETA PROTO-ONCOPROTEINS, REGULATES THE MURINE MYELOPEROXIDASE AND NEUTROPHIL ELASTASE GENES IN IMMATURE MYELOID CELLS [J].
NUCHPRAYOON, I ;
MEYERS, S ;
SCOTT, LM ;
SUZOW, J ;
HIEBERT, S ;
FRIEDMAN, AD .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (08) :5558-5568
[14]   AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis [J].
Okuda, T ;
vanDeursen, J ;
Hiebert, SW ;
Grosveld, G ;
Downing, JR .
CELL, 1996, 84 (02) :321-330
[15]  
ORKIN SH, 1992, BLOOD, V80, P575
[16]  
PEVNY L, 1995, DEVELOPMENT, V121, P163
[17]  
Rosenberg HF, 1999, INFLAMMATION BASIC P, P61
[18]  
Sanderson C J, 1990, Immunol Ser, V49, P231
[19]   CONTROL OF EOSINOPHILIA [J].
SANDERSON, CJ .
INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1991, 94 (1-4) :122-126
[20]   Absence of fetal liver hematopoiesis in mice deficient in transcriptional coactivator core binding factor beta [J].
Sasaki, K ;
Yagi, H ;
Bronson, RT ;
Tominaga, K ;
Matsunashi, T ;
Deguchi, K ;
Tani, Y ;
Kishimoto, T ;
Komori, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (22) :12359-12363